Fluralaner (ng/mL) | Pupal development control (%) | ||||||
---|---|---|---|---|---|---|---|
Exposure daya | |||||||
3 | 4 | 5 | 8 | 9 | 10 | Meanb | |
50.0 | NA | NA | NA | NA | NA | NA | NA |
25.0 | NA | NA | NA | NA | NA | NA | NA |
12.5 | 100 | NA | NA | 55.2 | 100 | NA | 85.1 |
6.25 | 90.2 | 92.4 | 87.3 | 86.4 | 89.9 | 86.0 | 88.7 |
3.13 | 66.3 | 68.9 | 61.7 | 70.3 | 62.1 | 57.4 | 64.5 |
1.56 | 35.3 | 36.3 | 34.6 | 35.5 | 41.6 | 27.2 | 35.1 |
0.78 | 7.5 | 11.4 | 16.7 | 10.8 | 11.9 | 14.5 | 12.1 |
0.39 | 9.8 | 0 | 1.5 | 3.3 | 6.3 | 0.8 | 3.6 |
0.19 | 8.8 | 0.2 | 6.8 | 0 | 2.7 | 0 | 3.1 |
0.09 | 9.1 | 4.5 | 1.4 | 0 | 5.9 | 2.9 | 4.0 |